REGENERON PHARMACEUTICALS, INC. (REGN)
Clinical trial NCT07543055 updates: 1. start date: 2026-05-14 → 2026-06-01 2. completion date: 2030-11-04 → 2031-03-20 3. primary completion date: 2029-12-13 → 2029-12-31 4. enrollment: not set → 36 participants
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical